Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Cash (2020 - 2025)

Journey Medical's Change in Cash history spans 6 years, with the latest figure at -$858000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 60.2% year-over-year to -$858000.0, compared with a TTM value of $3.8 million through Dec 2025, up 153.06%, and an annual FY2025 reading of $3.8 million, up 153.06% over the prior year.
  • Change in Cash for Q4 2025 was -$858000.0 at Journey Medical, down from $4.7 million in the prior quarter.
  • The five-year high for Change in Cash was $27.4 million in Q4 2021, with the low at -$9.1 million in Q2 2023.
  • Average Change in Cash over 5 years is $792200.0, with a median of -$1.2 million recorded in 2024.
  • Year-over-year, Change in Cash skyrocketed 527.25% in 2021 and then tumbled 435.86% in 2025.
  • Tracing DERM's Change in Cash over 5 years: stood at $27.4 million in 2021, then tumbled by 110.54% to -$2.9 million in 2022, then soared by 193.14% to $2.7 million in 2023, then plummeted by 180.15% to -$2.2 million in 2024, then surged by 60.2% to -$858000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Change in Cash are -$858000.0 (Q4 2025), $4.7 million (Q3 2025), and -$777000.0 (Q2 2025).